Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis
Rheumatology experts urge caution in using bisphosphonates to prevent bone loss
ACR/ARHP Annual Meeting 2012: How to Manage Gout Effectively in the Context of Comorbid Conditions
Comorbid conditions such as chronic kidney disease and cardiovascular disease can complicate gout management, but effective treatment and preventive strategies are available
What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
Foundation Research Explores Relationship Between RA and Cardiovascular Disease
A grant from the Rheumatology Research Foundation has set two physicians on a course to examine how high-density lipoprotein (HDL) cholesterol is different in rheumatoid arthritis patients
Coding Corner Answer: December Coding Challenge
Coding for an office visit by a patient with severe rheumatoid arthritis who experiences an adverse reaction to an infliximab infusion and has her IV flushed with saline and pushed with diphenhydramine.
ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease
More finely tuned view of ankylosing spondylitis leads to better treatment, expert says
CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions
The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit
Ethical Concerns Influence What Constitutes Clear and Full Disclosure for Physicians
Money received from industry by physicians who can influence medical practice by their research, opinions, or roles in decision-making bodies should be clearly and fully disclosed
Therapies Aimed at Immune Cell Progenitors May Be Key to Reducing Post Myocardial Infarction Risk
Researchers have identified hematopoietic stem and progenitor cells that are liberated from bone marrow niches by a myocardial infarction.
- « Previous Page
- 1
- …
- 300
- 301
- 302
- 303
- 304
- …
- 345
- Next Page »